629 related articles for article (PubMed ID: 27495947)
1. Venous thromboembolism in centenarians: Findings from the RIETE registry.
Lacruz B; Tiberio G; Núñez MJ; López-Jiménez L; Riera-Mestre A; Tiraferri E; Verhamme P; Mazzolai L; González J; Monreal M;
Eur J Intern Med; 2016 Dec; 36():62-66. PubMed ID: 27495947
[TBL] [Abstract][Full Text] [Related]
2. Fatal Events in Cancer Patients Receiving Anticoagulant Therapy for Venous Thromboembolism.
Farge D; Trujillo-Santos J; Debourdeau P; Bura-Riviere A; Rodriguez-Beltrán EM; Nieto JA; Peris ML; Zeltser D; Mazzolai L; Hij A; Monreal M;
Medicine (Baltimore); 2015 Aug; 94(32):e1235. PubMed ID: 26266353
[TBL] [Abstract][Full Text] [Related]
3. Vitamin K Antagonists After 6 Months of Low-Molecular-Weight Heparin in Cancer Patients with Venous Thromboembolism.
Chai-Adisaksopha C; Iorio A; Crowther MA; de Miguel J; Salgado E; Zdraveska M; Fernández-Capitán C; Nieto JA; Barillari G; Bertoletti L; Monreal M;
Am J Med; 2018 Apr; 131(4):430-437. PubMed ID: 29274307
[TBL] [Abstract][Full Text] [Related]
4. Subsequent arterial ischemic events in patients receiving anticoagulant therapy for venous thromboembolism.
Madridano O; del Toro J; Lorenzo A; Martín M; Gómez Cerezo J; Hernández L; Prandoni P; Monreal M;
J Vasc Surg Venous Lymphat Disord; 2015 Apr; 3(2):135-41.e1. PubMed ID: 26993830
[TBL] [Abstract][Full Text] [Related]
5. Venous thromboembolism in young adults: Findings from the RIETE registry.
Lacruz B; Tiberio G; Latorre A; Villalba JC; Bikdeli B; Hirmerova J; Lorenzo A; Mellado M; Cañas I; Monreal M;
Eur J Intern Med; 2019 May; 63():27-33. PubMed ID: 30871951
[TBL] [Abstract][Full Text] [Related]
6. Anticoagulation and venous thromboembolism in patients aged 90 years and older: Data from the RIETE registry.
Lafaie L; Poenou G; Hanon O; López-Jiménez L; Nieto JA; Lorenzo A; Porras JA; Lumbierres M; Bertoletti L; Monreal M;
J Am Geriatr Soc; 2024 Jan; 72(1):113-125. PubMed ID: 37814983
[TBL] [Abstract][Full Text] [Related]
7. Suboptimal doses of low molecular weight heparin and acute venous thromboembolism. Data from the RIETE registry.
Bruscas MJ; Nieto JA; Perez-Pinar M; López-Jiménez L; Fernández-Capitán C; López-Chuliá F; Orue-Lecue MT;
Ann Hematol; 2007 Jul; 86(7):519-26. PubMed ID: 17437112
[TBL] [Abstract][Full Text] [Related]
8. Venous thromboembolism in patients with glioblastoma multiforme: Findings of the RIETE registry.
Portillo J; de la Rocha IV; Font L; Braester A; Madridano O; Peromingo JA; Apollonio A; Pagán B; Bascuñana J; Monreal M;
Thromb Res; 2015 Dec; 136(6):1199-203. PubMed ID: 26548619
[TBL] [Abstract][Full Text] [Related]
9. Real-life treatment of venous thromboembolism with direct oral anticoagulants: The influence of recommended dosing and regimens.
Trujillo-Santos J; Di Micco P; Dentali F; Douketis J; Díaz-Peromingo JA; Núñez MJ; Cañas I; Mastroiacovo D; Saraiva de Sousa M; Monreal M;
Thromb Haemost; 2017 Jan; 117(2):382-389. PubMed ID: 27786333
[TBL] [Abstract][Full Text] [Related]
10. Recurrence of venous thromboembolism in patients with recent gestational deep vein thrombosis or pulmonary embolism: Findings from the RIETE Registry.
Barillari G; Londero AP; Brenner B; Nauffal D; Muñoz-Torrero JF; Del Molino F; Moustafa F; Madridano O; Martín-Martos F; Monreal M;
Eur J Intern Med; 2016 Jul; 32():53-9. PubMed ID: 26972931
[TBL] [Abstract][Full Text] [Related]
11. Venous thromboembolism in immobilized patients with dementia. Findings from the RIETE registry.
Nuñez MJ; Villalba JC; Cebrián E; Visoná A; Lopez-Jimenez L; Núñez M; Szwebel TA; Luque JM; Jaras MJ; Monreal M;
Thromb Res; 2012 Aug; 130(2):173-7. PubMed ID: 22374336
[TBL] [Abstract][Full Text] [Related]
12. Outcomes Associated With Inferior Vena Cava Filters Among Patients With Thromboembolic Recurrence During Anticoagulant Therapy.
Mellado M; Pijoan JI; Jiménez D; Muriel A; Aujesky D; Bertoletti L; Decousus H; Barrios D; Clará A; Yusen RD; Monreal M;
JACC Cardiovasc Interv; 2016 Dec; 9(23):2440-2448. PubMed ID: 27838262
[TBL] [Abstract][Full Text] [Related]
13. Venous thromboembolism in radiation therapy cancer patients: Findings from the RIETE registry.
Guy JB; Bertoletti L; Magné N; Rancoule C; Mahé I; Font C; Sanz O; Martín-Antorán JM; Pace F; Vela JR; Monreal M;
Crit Rev Oncol Hematol; 2017 May; 113():83-89. PubMed ID: 28427527
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness and safety of rivaroxaban versus warfarin for treatment and prevention of recurrence of venous thromboembolism.
Coleman CI; Bunz TJ; Turpie AGG
Thromb Haemost; 2017 Oct; 117(10):1841-1847. PubMed ID: 28640322
[TBL] [Abstract][Full Text] [Related]
15. Venous thromboembolism during pregnancy or postpartum: findings from the RIETE Registry.
Blanco-Molina A; Trujillo-Santos J; Criado J; Lopez L; Lecumberri R; Gutierrez R; Monreal M;
Thromb Haemost; 2007 Feb; 97(2):186-90. PubMed ID: 17264945
[TBL] [Abstract][Full Text] [Related]
16. Management patterns and outcomes of patients with venous thromboembolism in the usual community practice setting.
Willey VJ; Bullano MF; Hauch O; Reynolds M; Wygant G; Hoffman L; Mayzell G; Spyropoulos AC
Clin Ther; 2004 Jul; 26(7):1149-59. PubMed ID: 15336480
[TBL] [Abstract][Full Text] [Related]
17. Gender differences in patients with venous thromboembolism and five common sites of cancer.
Martín-Martos F; Trujillo-Santos J; Del Toro J; Bura-Riviere A; Lorenzo A; Barillari G; Soler S; Mahè I; Sahuquillo JC; Monreal M;
Thromb Res; 2017 Mar; 151 Suppl 1():S16-S20. PubMed ID: 28262228
[TBL] [Abstract][Full Text] [Related]
18. Tinzaparin vs Warfarin for Treatment of Acute Venous Thromboembolism in Patients With Active Cancer: A Randomized Clinical Trial.
Lee AYY; Kamphuisen PW; Meyer G; Bauersachs R; Janas MS; Jarner MF; Khorana AA;
JAMA; 2015 Aug; 314(7):677-686. PubMed ID: 26284719
[TBL] [Abstract][Full Text] [Related]
19. Gender-related differences in the outcome of patients with venous thromboembolism and thrombophilia.
Tzoran I; Papadakis E; Brenner B; Valle R; López-Jiménez L; García-Bragado F; Riera-Mestre A; Villalobos A; Quintavalla R; Monreal M;
Thromb Res; 2017 Mar; 151 Suppl 1():S11-S15. PubMed ID: 28262227
[TBL] [Abstract][Full Text] [Related]
20. Deep venous thrombosis and pulmonary embolism. Part 2--Prevention of recurrences: warfarin or low-molecular-weight heparin for at least 3 months.
Prescrire Int; 2013 May; 22(138):129-33. PubMed ID: 23819181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]